Bovine herpesvirus 1 (BHV-1) is a member of the Alphaherpesvirinae subfamily and is the prototype ruminant herpesvirus. BHV-1 causes a number of complications in cattle including upper respiratory tract disorders, conjunctivitis, genital disorders, abortions, and immune suppression. Like all herpesviruses, reactivation from latency can occur throughout the animal’s life. Of particular economic importance is the bovine respiratory disease complex (BRDC) or ‘shipping fever’, in which BHV-1 plays a major role. BRDC is an enormous economic concern as it costs the US cattle industry approximately one billion dollars annually. In order to generate improved gene-deleted vaccines against BHV-1, there is a need to understand the contributions of viral gene products during infection. US3 is a serine/threonine kinase present in BHV-1 and is thought to play major roles during viral infection. As in other herpesviruses, US3 in BHV-1 is expected to phosphorylate several cellular and/or viral proteins. We recently presented evidence that BHV-1 US3 phosphorylates both VP8 and VP22; however, further functional characteristics of BHV-1 US3 during viral infection have not been elucidated. The hypothesis of this project is that the deletion of the US3 gene leads to reduced BHV-1 fitness. To explore this hypothesis, we generated a US3-deleted (ΔUS3) and subsequent US3-rescued (US3R) BHV-1 virus. Using these viral mutants, we characterized the growth properties of the viruses, evaluated the effect of the US3 deletion on major structural BHV-1 proteins, characterized the protein composition of the mature virions, and, identified viral processes that were impaired in the deletion mutant. Initially, the ∆US3 virus was generated through a 3-step PCR strategy which replaced the gene of interest with an antibiotic resistance cassette. Following this, the US3 gene was rescued via a two-step en passant mutagenesis strategy which has been previously used to generate insertions, deletions, and substitutions in herpesvirus-containing bacterial artificial chromosome (BAC) DNA. In vitro characterization of ∆US3 BHV-1 has demonstrated that US3 deletion affects BHV-1 growth characteristics, expression kinetics of major structural proteins, mature virion composition, cell to cell spread, and the subcellular localization of key viral proteins during infection. Growth kinetics of ∆US3 BHV-1 were impaired compared to wild-type (WT) BHV-1, especially at late times post-infection. Plaque sizes formed by ∆US3 BHV-1 were significantly smaller than those formed by either WT or US3R BHV-1, demonstrating that US3 is important for cell to cell spread. The expression kinetics of major structural and regulatory BHV-1 proteins were different between cells infected with ∆US3 or WT BHV-1, and incorporation of these proteins into the mature viruses differed, demonstrating that US3 is instrumental in ensuring proper protein expression and mature virus composition in vitro. Of particular importance, glycoprotein B (gB), was shown to be expressed in higher quantities earlier during infection in the absence of US3, and that this protein was incorporated in significantly higher amounts in mature virions which lacked US3. Qualitative analysis of ∆US3 BHV-1 infected monolayers suggested the abolishment of cell to cell projections characteristic of WT BHV-1 infection. Finally, the disruption of gB in ∆US3 BHV-1 infected cells was confirmed by confocal microscopy and fluorescence-activated cell sorting (FACS) analysis. Through confocal microscopy, evidence was provided that infection with ∆US3 BHV-1 possibly results in earlier expression of gB on the surface of cells and less intracellular accumulation of this protein during late stages of infection. The observed effect on the localization of intracellular gB in ∆US3 BHV-1 infected cells was quantified by flow cytometry. ∆US3 BHV-1 infected cells had approximately 25% higher gB expression on the surface of cells and a corresponding 25% decrease in intracellular gB. Although these differences have not yet been demonstrated to be statistically significant and not confirmed through infection with US3R BHV-1, this suggests that US3 may influence the synthesis and cellular trafficking of gB in vitro.

Formalized epidemiological field investigations were conducted to compare and contrast the transmission dynamics of EHV-1 neurological disease among horses stabled at Churchill Downs Racetrack, Louisville, Kentucky and of EHV-1 respiratory illness among horses stabled in the student barn at Murray State University. Differences were assessed by means of statistical and mathematical modeling techniques applied to survey and biological data collected over the course of the respective disease events. Regression methods applied to survey data enabled the construction of a statistical model to predict a date of onset of illness for horses within each equine cohort. Comparisons of the epidemic curves revealed that the Murray State University outbreak was 4.5 times longer (9 weeks versus 14 days) than the Churchill Downs Racetrack event. Survival analysis was used to explore the relationship between time to infection for each equine cohort. Horses stabled in the affected barn at Churchill Downs racetrack had a 3.02 times greater daily risk (p < 0.001) for contracting EHV-1 infection relative to horses stabled in the student barn at Murray State University. Estimates of the basic R0 number, calculated using mathematical formulae that incorporated the duration of the infectious period for neuropathogenic and nonneuropathogenic strains of EHV-1, were 10.25 and 2.94 for the Churchill Downs racetrack and Murray State University outbreaks, respectively. The generation time for the Churchill Downs outbreak was 6.1 times shorter (0.39 days versus 2.38 days) than for the Murray State University event. An assessment of the temporal occurrence of symptomatic infection is similar for each event and suggests that the appearance of clinical illness is constant over the course of an outbreak. A Reed-Frost model was constructed for each EHV-1 event where values of the transmission parameters (q, p and k) were estimated by fitting a model that most closely matched the observed profile of EHV-1 cases. The value of prophylactic vaccination on the spread of EHV-1 was assessed by making adjustments to these fitted models for varying levels of herd immunity. The results indicate that the prevention of EHV-1 neurological illness requires a higher level of herd immunity than EHV-1 respiratory illness.

Sabe-se que um dos principais problemas odontológicos na clínica de felinos é a gengivite crônica e intratável. Tal afecção pode ser iniciada e/ou exacerbada por agentes virais, como o vírus da imunodeficiência dos felinos (FIV), o Herpesvírus tipo 1 e o Calicivírus. Os gatos da raça Maine Coon apresentam grande predisposição ao desenvolvimento de gengivite-estomatite juvenil e intratável. A depleção de linfócitos T CD4+ e T CD8+ pode exercer papel determinante na iniciação e manutenção das doenças inflamatórias da gengiva. O escopo do presente estudo foi verificar se os animais da raça Maine Coon são mais predispostos à calicivirose, bem como avaliar quantitativamente a resposta imunológica celular, mediada por linfócitos TCD4+ e TCD8+, visando a correlacionar à influência do número de linfócitos na presença e curso da gengivite nesta determinada raça, utilizando-se como controle gatos de outras raças com e sem gengivite. Os valores absolutos médios de linfócitos totais em Maine Coons com gengivite crônica mostraram-se inferiores aos de gatos da raça Maine Coon sem doença oral e de gatos de outras raças com gengivite crônica (p<0,05); os valores médios de linfócitos TCD4+ em Maine Coons com gengivite crônica mostraram-se inferiores quando comparados aos valores de animais da mesma raça, sem doença oral instalada (p<0,05); animais da raça Maine Coon possuem menor relação CD4+:CD8+ quando comparados a animais de outras raças com gengivite crônica e também quando comparados a Maine Coons sem doença oral (p<0,05). O calicivírus está altamente relacionado à ocorrência da gengivite, independentemente da raça estudada, não havendo maior prevalência na raça Maine Coon. O efeito do calicivírus não foi significativo nas alterações de nenhuma das variáveis celulares estudadas. Tais fatos apontam para uma possível predisposição racial ao quadroinflamatório gengival, com alteração de alguns componentes celulares relacionados à imunidade celular. Isto tem como fator importante alertar o clínico frente ao uso de glicocorticóides no tratamento da gengivite crônica nesta raça, visando a evitar maior comprometimento da imunidade celular destes animais. / Chronic untreatable feline gingivitis is widely recognized as one of the major oral diseases seen in feline patients. It can be either triggered or exacerbated by virus such as feline immunodeficiency virus, feline herpesvirus type 1 and calicivirus. One may therefore propose that lymphocytes T CD4+ and T CD8+ depletion can play an important role in initiating and maintaining the inflammatory gingival disease. Maine Coon cats are highly predisposed to juvenile untreatable gingivitis. The purpose of this study was to evaluate whether Maine Coon cats are more predisposed to calicivirus infection and to verify, quantitatively, their immunological cellular response mediated by lymphocytes T CD4+ and TCD8+. The main idea was to investigate the influence imposed by lymphocyte counts in gingivitis development and progression within this breed; for this, we selected non-Maine Coon cats (with and without gingivitis) to serve as controls. Mean absolute values of total lymphocytes in Maine Coon cats presented with gingivitis were inferior than the same values taken for both Maine Coon cats free of oral disease and non-Maine Coon cats with chronic gingivitis (p<0,05); lymphocytes TCD4+ average values in Maine Coon cats with chronic gingivitis were also lower than the ones taken from cats of the same breed but without oral disease (p<0,05). Maine Coon cats have lower CD4+:CD8+ ratio when compared to non-Maine Coon cats with chronic gingivitis as well as with Maine Coon cats without oral disease (p<0,05). The calicivirus is highly involved with the occurrence of gingivitis, no matter the breed being evaluated. The action virus imposes in changing cellular immunology was not significant, at least considering the cellular variables studied. All these lead us to point out a possible breed predisposition to the gingival inflammation, with modification of some cellular components related with cellular immunity. Furthermore, concerning practical terms, these results serve as a relevant alert to the clinicians regarding the use of glucocorticoids for treating chronic gingivitis in this breed, in order to prevent further impairment of cellular immunity of these animals.

Equine Herpesvirus type 1 (EHV-1) is a worldwide threat to the health of horses. It can cause mild respiratory disease, abortions and deaths of newborn foals as well as a potentially fatal neurologic disorder known as Equine Herpesvirus Myeloencephalopathy (EHM). The virus is maintained in populations by stress-induced periodic reactivation of virus in long-term latently infected horses and transmission of the reactivated virus to susceptible individuals. In horses, peripheral blood leukocytes (PBLs) are thought to be an important site for EHV-1 latent genomes. Since the Unfolded Protein Response (UPR) is a cellular response to a variety of stressors that has been linked to reactivation of herpes simplex virus in humans, a virus closely related to EHV-1, I tested the hypothesis that latent EHV-1 relies on the UPR as a pluripotent stress sensor and uses it to reactivate lytic gene expression. Since little work has been done in defining the UPR in horses, I first successfully developed a quantitative real-time polymerase chain reaction (RT-qPCR) assay to detect and quantitate transcripts for selected UPR genes in equine dermal (E.Derm) cells and PBLs. Activation of the UPR was achieved in both cell types using thapsigargin and a difference in gene expression after activation of the UPR in two equine cell types was found. A nested PCR assay to detect and distinguish latent EHV-1 and EHV-4 was evaluated and the sensitivity of the technique to detect EHV-1 was determined. I discovered that the nested PCR technique was not sensitive enough to detect the estimated one latent viral genome in 50,000 PBLs. Lytic EHV-1 infection was characterized by single step growth curve in E.Derm cells and consistent detection of temporal EHV-1 gene expression by RT-qPCR was achieved. The relationship between EHV-1 gene expression and UPR gene expression during lytic infection was investigated. While EHV-1 infection had no effect on UPR gene expression, activation of the UPR appeared to decrease the expression of EHV-1 genes temporarily and reversibly during the first 4 h after infection. Finally, detection of EHV-1 in PBLs from horses presumed to be latently infected by co-cultivation with E. Derm cells permissive to EHV-1 infection was attempted. To detect viral DNA, PBLs were stimulated with thapsigargin or interleukin 2 (IL-2) which was previously reported to induce reactivation of latent EHV-1. I was not able to reproduce previously published experiments of reactivation in vitro of latent EHV-1 by stimulation with IL-2, and virus reactivation did not occur after stimulation of PBLs with thapsigargin. In summary, a RT-qPCR assay to measure the expression of equine UPR genes was developed and activation of the UPR by treatment of E.Derm cells and PBLs with thapsigargin was successfully achieved. A difference in gene expression after activation of the UPR in two equine cell types was found. In contrast to what has been reported for other alphaherpesviruses, there appears to be no, or only little, interaction between the UPR and EHV-1 during viral infection. Detection of latent EHV-1 genomes in PBLs was not achieved by using a nested PCR, as this technique was not sensitive enough to detect the estimated one latent viral genome in 50,000 PBLs. Finally, latent EHV-1 was not detected in presumed latently infected PBLs or reactivated by triggering the UPR in equine PBLs.

Sabe-se que um dos principais problemas odontológicos na clínica de felinos é a gengivite crônica e intratável. Tal afecção pode ser iniciada e/ou exacerbada por agentes virais, como o vírus da imunodeficiência dos felinos (FIV), o Herpesvírus tipo 1 e o Calicivírus. Os gatos da raça Maine Coon apresentam grande predisposição ao desenvolvimento de gengivite-estomatite juvenil e intratável. A depleção de linfócitos T CD4+ e T CD8+ pode exercer papel determinante na iniciação e manutenção das doenças inflamatórias da gengiva. O escopo do presente estudo foi verificar se os animais da raça Maine Coon são mais predispostos à calicivirose, bem como avaliar quantitativamente a resposta imunológica celular, mediada por linfócitos TCD4+ e TCD8+, visando a correlacionar à influência do número de linfócitos na presença e curso da gengivite nesta determinada raça, utilizando-se como controle gatos de outras raças com e sem gengivite. Os valores absolutos médios de linfócitos totais em Maine Coons com gengivite crônica mostraram-se inferiores aos de gatos da raça Maine Coon sem doença oral e de gatos de outras raças com gengivite crônica (p<0,05); os valores médios de linfócitos TCD4+ em Maine Coons com gengivite crônica mostraram-se inferiores quando comparados aos valores de animais da mesma raça, sem doença oral instalada (p<0,05); animais da raça Maine Coon possuem menor relação CD4+:CD8+ quando comparados a animais de outras raças com gengivite crônica e também quando comparados a Maine Coons sem doença oral (p<0,05). O calicivírus está altamente relacionado à ocorrência da gengivite, independentemente da raça estudada, não havendo maior prevalência na raça Maine Coon. O efeito do calicivírus não foi significativo nas alterações de nenhuma das variáveis celulares estudadas. Tais fatos apontam para uma possível predisposição racial ao quadroinflamatório gengival, com alteração de alguns componentes celulares relacionados à imunidade celular. Isto tem como fator importante alertar o clínico frente ao uso de glicocorticóides no tratamento da gengivite crônica nesta raça, visando a evitar maior comprometimento da imunidade celular destes animais. / Chronic untreatable feline gingivitis is widely recognized as one of the major oral diseases seen in feline patients. It can be either triggered or exacerbated by virus such as feline immunodeficiency virus, feline herpesvirus type 1 and calicivirus. One may therefore propose that lymphocytes T CD4+ and T CD8+ depletion can play an important role in initiating and maintaining the inflammatory gingival disease. Maine Coon cats are highly predisposed to juvenile untreatable gingivitis. The purpose of this study was to evaluate whether Maine Coon cats are more predisposed to calicivirus infection and to verify, quantitatively, their immunological cellular response mediated by lymphocytes T CD4+ and TCD8+. The main idea was to investigate the influence imposed by lymphocyte counts in gingivitis development and progression within this breed; for this, we selected non-Maine Coon cats (with and without gingivitis) to serve as controls. Mean absolute values of total lymphocytes in Maine Coon cats presented with gingivitis were inferior than the same values taken for both Maine Coon cats free of oral disease and non-Maine Coon cats with chronic gingivitis (p<0,05); lymphocytes TCD4+ average values in Maine Coon cats with chronic gingivitis were also lower than the ones taken from cats of the same breed but without oral disease (p<0,05). Maine Coon cats have lower CD4+:CD8+ ratio when compared to non-Maine Coon cats with chronic gingivitis as well as with Maine Coon cats without oral disease (p<0,05). The calicivirus is highly involved with the occurrence of gingivitis, no matter the breed being evaluated. The action virus imposes in changing cellular immunology was not significant, at least considering the cellular variables studied. All these lead us to point out a possible breed predisposition to the gingival inflammation, with modification of some cellular components related with cellular immunity. Furthermore, concerning practical terms, these results serve as a relevant alert to the clinicians regarding the use of glucocorticoids for treating chronic gingivitis in this breed, in order to prevent further impairment of cellular immunity of these animals.

As alterações inflamatórias que afetam a cavidade oral e a gengiva dos felinos são frequentemente observadas na rotina médica e constituem verdadeiro desafio diagnóstico e terapêutico ao clínico. Denomina-se complexo gengivite-estomatitefaringite felina (CGEF) como sendo uma síndrome onde a apresentação clínica comum é a inflamação grave da gengiva e mucosa oral. A etiopatogênese desta doença não está totalmente elucidada mas acredita-se que seja multifatorial. As viroses têm sido implicadas como agentes etiológicos na patogenia da gengivite-estomatite crônica felina, entretanto, o mecanismo pelo qual as infecções virais participam no desenvolvimento da doença gengival nos animais afetados permanece indeterminado. A hipótese do presente estudo é de que a depleção imunológica induzida pelo lentivírus felino (FIV) aumenta o risco de ocorrência do FCV e do FHV-1 e da estomatite-gengivite em gatos. Para tanto, foram realizados 2 experimentos: o primeiro (A) foi delineado para avaliar a ocorrência do FCV e do FHV-1 na cavidade oral de 58 gatos naturalmente infectados pelo FIV ou não, com e sem gengivite, por meio da reação de polimerização em cadeia (PCR), assim como correlacionar esses achados com as subpopulações de linfócitos T CD4+, CD8+ e da razão CD4+:CD8+ e o segundo (B) foi desenvolvido para avaliar a correlação do FCV e das subpopulações de linfócitos T CD4+ com os diferentes graus de estomatite-gengivite em 35 gatos naturalmente infectados pelo FIV ou não, divididos em 2 grupos. No experimento A, pôde-se determinar que apenas o FCV está relacionado à inflamação gengival, sendo detectado em 88,9% dos gatos com gengivite. Além disso, a infecção pelo FIV promoveu aumento significativo do número de linfócitos T CD8+ (p=0,004) e diminuição da razão CD4+:CD8+ (p<0,001). No experimento B, identificou-se que a infecção pelo FIV está associada à ocorrência da infecção pelo FCV (p=0,011), à presença de gengivite (p=0,022) e ao grau de gengivite (p<0,001), sendo que os gatos infectados pelo FIV foram os que apresentaram graus mais graves de gengivite. Portanto, no grupo dos animais infectados pelo FIV pôde-se observar maior ocorrência do FCV e presença de gengivite. Adicionalmente, o grau de gengivite está diretamente associado à infecção pelo FCV (p<0,001), onde os animais positivos para este vírus apresentaram graus mais graves de gengivite. Pelo presente estudo, pôde-se concluir que a ocorrência da infecção pelo FCV está diretamente associada ao CGEF em felinos e que a ocorrência do FCV foi significativa em animais que apresentaram graus mais graves de gengivite. Além disso, os gatos que apresentaram graus mais graves de gengivite, foram os que apresentaram menores valores de linfócitos T CD4+ e maior ocorrência de infecção pelo FCV. Contudo, não é possível saber se a co-infecção pelo FIV e FCV foi responsável pelo agravamento da gengivite e da condição imunológica dos gatos ou se a disfunção do sistema imune causada pelo FIV predispôs a infecção pelo FCV, levando a piora das lesões orais. / The inflammation that affects the oral cavity and the gingiva of felines are frequently observed in the medical practice and constitute a true diagnosis and therapy challenge to the physician. This condition is referred to as feline gingivitis-stomatitis-pharyngitis complex (FGSC) and it is a syndrome in which the common clinical profile is a severe gingival and oral mucosa inflammation. The etiopathogenesis of this disease is not completely elucidated but it is believed to be multifactorial. The viruses have been involved as etiologic agents in the feline chronic gingivitis-stomatitis pathogeny, however, the mechanism through which the viral infections participate in the development of the gingival disease of the infected animals remains undetermined. The present studys hypothesis is that the immunedepletion induced by the feline lentivirus (FIV) increases the risk of development of FCV and FHV-1, and stomatitis-gingivitis in cats. In order to do so, two experiments were conducted: the first one (A) was designed to evaluate the occurrence of FCV and FHV-1 in the oral cavity of 58 cats naturally infected by FIV or not, with and without gingivitis, through polymerase chain reaction (PCR), and to correlate this findings with the subpopulations of lymphocytes T CD4+, CD8+ and the ratio of CD4+:CD8+; the second one (B) was developed to evaluate the correlation of the FCV and of the subpopulations of lymphocytes T CD4+ with the different degrees of stomatitis-gingivitis in 35 cats naturally infected by the FIV or not, divided into two groups. In the experiment A, it was possible to determine that only the FCV is related to gingivitis, being detected in 88.9% of the cats with gingivitis. Moreover, the FIV infection promoted a significant increase in the number of lymphocytes T CD8+ (p=0.004) and a decrease of the ratio CD4+:CD8+ (p<0.001). In the experiment B, the FIV infection is associated to the occurrence of gingivitis due to the FCV (p=0.011), to the presence of gingivitis (p=0.022), and to the degree of gingivitis (p<0.001), being that the FIV infected cats were the ones that presented the more severe degrees of gingivitis. Therefore, in the group of animals infected by the FIV it was possible to observe a greater occurrence of FCV and the presence of gingivitis. Additionally, the degree of gingivitis is directly related to the FCV infection (p<0.001), where the animals that tested positive for this virus presented more severe degree of gingivitis. From the present study, it was possible to conclude that the occurrence of infection due to the FCV is directly related to FGSC in felines and that the occurrence of FCV was significant in animals that presented more severe degrees of gingivitis. Moreover, the cats that presented more severe degrees of gingivitis were the ones that presented lower values of lymphocytes T CD4+ and greater occurrence of FCV infection. However, it is not possible to know whether the co-infection due to the FIV and the FCV was responsible for the worsening of the gingivitis and of the immune condition of the cats, or if the immune system dysfunction caused by the FIV predisposed the FCV infection, leading to the aggravation of the oral lesions.

No presente estudo, buscou-se avaliar quais seriam as cepas de herpesvírus bovinos tipos 1 (BoHV-1) e 5 (BoHV-5) seriam mais adequadas para uso como vírus de confrontação em testes de soroneurtralização (SN). Oitocentas e dez amostras de soros de duas regiões geograficamente distintas foram avaliadas à SN frente a seis diferentes cepas virais, incluindo tipos e subtipos diversos (BoHV-1.1: EVI123/98 e Los Angeles; BoHV-1.2a: SV265/96; BoHV-5a: EVI88/95; BoHV-5b: A663 e BoHV-5c: ISO95/97). A maior sensibilidade foi revelada pelo somatório de soropositivos identificados com as seis cepas utilizadas no estudo. Uma combinação de quatro vírus (BoHV-1.1: LA e EVI123/98, BoHV-5a: EVI88/95 e BoHV-5b: A663) foi capaz de detectar 99,1% das amostras soropositivas. Estes quatro vírus foram selecionados para serem utilizados em um levantamento soroepidemiológico com o intuito de estimar a prevalência das infecções causadas pelos BoHV-1 e BoHV-5 no Estado do Rio Grande do Sul. Para tanto, soros de 2200 fêmeas bovinas adultas (>24 meses), representativos da população bovina do Rio Grande do Sul, foram submetidos à SN frente às quatro cepas virais escolhidas. om esta combinação, a soroprevalência média das infecções por BoHV-1 e BoHV-5 encontrada foi de 29,2%. Além disso, analisando outros fatores que pudessem influenciar a prevalência das infecções, foram considerados fatores de risco o tipo de exploração corte, a ausência da prática de ordenha, o contato dos bovinos com ovinos/caprinos e animais silvestres, a venda de animais de reprodução, o uso de piquetes de parto/pós-parto, o uso de assistência veterinária privada e a criação de animais de raças européias de corte. Os resultados obtidos no presente trabalho demonstraram que, para que a SN seja capaz de detectar animais soropositivos ao BoHV-1 e BoHV-5 com a máxima sensibilidade, o teste deve ser realizado com várias amostras de BoHV-1 e BoHV-5, não necessariamente de tipos ou subtipos diferentes, pois amostras do mesmo tipo de vírus apresentarrm diferentes sensibilidades. Além disso, as amostras de confrontação podem variar de acordo com a região geográfica de origem dos soros. Os resultados obtidos nesse levantamento revelam que anticorpos anti-BoHV-1 e anti-BoHV-5 encontram-se amplamente distribuidos nos rebanhos gaúchos. No entanto, não foi possível determinar a prevalência tipo-específica destas infecções com os testes realizados. Assim, a proporção de animais que estão infectados com o BoHV-1 ou com o BoHV-5 (ou ambos) na região examinada permanece desconhecida. / In this study a search was carried out to determine which of a number of available strains/isolates of bovine herpesviruses types 1 (BoHV-1) and 5 (BoHV-5) would be more suitable for use as challenge virus in serum neutralization (SN) tests. Eight hundred and ten bovine serum samples collected from two geographically distinct regions were evaluated in SN tests against six BoHVs of different types and subtypes (BoHV-1.1: EVI123/98 and Los Angeles; BoHV-1.2a: SV265/96; BoHV-5a: EVI88/95; BoHV-5b: A663 and BoHV-5c: ISO95/97). The highest sensitivity was achieved when the SN-positive sera obtained with the six different viruses were added. A combination of four viruses (BoHV-1.1 LA, and EVI123/98, BoHV-5a EVI88/95 and BoHV-5b A663), was able to detect 99.1% of the seropositive samples. These four viruses were selected to carry out a seroepidemiological survey to estimate BoHV-1 and BoHV-5 prevalence in the state of Rio Grande do Sul. In order to achieve that, sera from 2,200 bovine female cows (>24 months-old), representative of the bovine population of Rio Grande do Sul state were tested on SN tests against the four selected viruses. With such combination, seroprevalence of BoHV-1 and BoHV-5 infections was 29.2%. After examining potential factors that might affect the prevalence of such infections, the following were considered as significant risk factors: the type of exploitation (beef cattle > dairy), use of milking procedures, concomitant presence of sheep, goats or wild animals in farm; sale of animals for reproductive purposes; use of pre and postparturition paddocks; use of private veterinary assistance and farming of European beef breeds. The results obtained here indicate that for the SN test to provide the highest sensitivity in detecting BoHV-1 and BoHV-5 seroposivive animals, it must be performed against a number of BoHV-1 and BoHV-5 strains, though not necessarily of different types and subtypes as viruses within a same subtype may display different sensitivities. Besides, challenge viruses may vary for geographically distinct areas. The serological survey performed with four distinct bovine herpesviruses reveal that antibodies to BoHV-1 and BoHV-5 are widely distributed among cattle flocks in Rio Grande do Sul. However, it was not possible to determine type-specific prevalence with the tests performed. Thus, the proportion of cattle actually infected with either BoHV-1 or BoHV-5 (or both) in the examined region remains undetermined.

O herpesvírus bovino tipo 1 (BoHV-1) é um dos principais agentes causadores de prejuízos econômicos em criações de bovinos. A vacinação tem sido amplamente utilizada para minimizar as perdas causadas por infecções pelo BoHV-1. Dentre as vacinas disponíveis, as vacinas desenvolvidas a partir de amostras virais recombinantes apresentam a vantagem de permitirem a diferenciação entre animais infectados e imunizados. Anteriormente, foi desenvolvida uma vacina recombinante diferencial com uma amostra de BoHV-1 brasileira baseada na deleção do gene que codifica a glicoproteína E (gE). No primeiro capítulo do presente trabalho, a segurança e imunogenicidade desta vacina recombinante inativada foi avaliada. Os experimentos de imunização, desafio e reativação da vacina diferencial em animais experimentalmente inoculados demonstraram que a vacina recombinante foi segura e eficiente ao minimizar ou mesmo prevenir os efeitos da infecção pelo BoHV-1. No segundo capítulo, a segurança da vacina gE- foi avaliada, através da imunização intramuscular (IM) de 22 vacas (14 BoHV-1 soronegativas e 8 soropositivas) prenhes. Foi observada soroconverão, mas não abortos e nem anormalidades fetais nos animais imunizados. Na segunda parte do mesmo estudo foi analizada a capacidade do vírus recombinante difundir-se em um rebanho bovino. Quatro terneiros foram inoculados pela rota intranasal (IN) com a amostra recombinante gE- e, posteriormente, adicionados a outros 16 animais com mesma idade e semelhante condição corporal durante 180 dias. Todos os animais foram monitorados diariamente em busca de sintomatologia clínica. Foi observada soroconversão apenas nos animais imunizados. Estes resultados indicam que, nas condições deste estudo, a amostra recombinante não causou nenhum dano nas vacas prenhes ou em seus terneiros e não foi capaz de difundir-se horizontalmente no rebanho. No terceiro capítulo foi avaliada a patogenicidade de uma amostra recombinante de BoHV-1 com deleção no gene Us9, utilizando coelhos como modelo experimental. Coelhos com quatro semanas de idade foram divididos em quatro grupos (A, B, C, D). Dois grupos (A e B) foram infectados via intranasal (IN) e dois (C e D) infectados via intraocular (IO). Em cada via de infecção, um grupo foi infectado com o vírus recombinante e o outro com o vírus selvagem (wt). Após a infecção IO, todos os animais, de ambos os grupos, desenvolveram intensa conjuntivite entre os dias 3 a 10 pós-inoculação (pi). Vírus infeccioso foi consistentemente isolado a partir dos suabes oculares entre os dias 1 a 10 pi chegando a um título máximo de 103,05 TCID50/mL. Nos grupos infectados pela via IN com BoHV-1 wt, 4/4 coelhos apresentaram sintomatologia característica da doença, tais como: pirexia, apatia, anorexia, tosse, secreção nasal severa (entre os dias 2 e 8 pi). Animais inoculados com o recombinante apresentaram apatia, anorexia e descarga nasal (entre os dias 3 e 7 pi). Vírus infeccioso foi isolado em diversos tecidos tanto nos animais inoculados com o vírus wt como recombinante. Ambos os vírus foram capazes de replicar nas mucosas. Análises histológicas dos tecidos dos animais demonstraram lesões em ambos os grupos. Este estudo apresentou que a proteína Us9 não tem um papel significante na patogenicidade in vivo. / Bovine herpesvirus type 1 (BoHV-1) is an the major cause of losses in cattle. Vaccination has been widely applied to minimize losses induced by BoHV-1 infections. Vacines developed from recombinant strains have the advantage of allow the differentiation between immunized and infected animals. Previously, a recombinant differential BoHV-1 vaccine based on a glycoprotein E deleted (gE) virus was developed. In the first chapter of the present work, the safety and immunogenicity of such recombinant, as a inactivate vaccine, was evaluated. The experiments showed that the DIVA vaccinne was safe and efficient in order to minimize or even prevent the clinical signs of the infection by BoHV- 1. In the second chapter of the present study, the safety of the gE- vaccine during pregnancy was evaluated by the intramuscular inoculation into 22 pregnant dams (14 BoHV-1 seronegative; 8 seropositive). Seroconversion was detected but no abortions, stillbirths or fetal abnormalities were seen after vaccination. In the second part of the same study, the potential of the gE- vaccine virus to spread among beef cattle under field conditions was examined. Four heifers were inoculated intranasally (IN) with the gE- vaccine and mixed with other 16 animals at the same age and body conditions, for 180 days. All animals were daily monitored for clinical signs.. Seroconversion was observed only in vaccinated heifers. These results indicate that, under the conditions of the present study, the gE vaccine virus did not cause any noticeable harmful effect on pregnant dams and on its offspring and did not spread horizontally among cattle. In the third chapter the pathogenicity of a US9 negative recombinant strain BoHV-1 using rabbits as an experimental model was avaluated. Rabbits four weeks old were divided in four groups (A, B, C, D) within four rabbits per group. Two groups were infected IN route and two via intraocular (IO). In each route, one group was infected by recombinant virus and the other infected by wild type (wt) virus. After IO infection, all rabbits developed intense conjunctivitis between days 3 to 10 pos infection (pi). Infective virus was consistently isolated from ocular swabs on days 1 to 10, reaching a maximum of 103.05 TCID50/mL. Animals infected in the IN rote with BoHV-1 wt, 4/4 rabbits showed characteristic signs of disease, which included pyrexia, apathy, anorexia, cough, severe nasal secretion between days 2 to 8. Rabbits inoculated with recombinant virus showed apathy, anorexia, nasal secretion (between days 3 and 7pi). Infectious virus was isolated in differents tissues as much as animals inoculated with wt and recombinant virus. Both virus were capable of replication in the mucosa nasal and ocular of the inoculated rabbits. Histopatological lesions were evident in both groups. In the present study showed which the US9 protein have not significantly in the pathogenicity in vivo.

No presente estudo, buscou-se avaliar quais seriam as cepas de herpesvírus bovinos tipos 1 (BoHV-1) e 5 (BoHV-5) seriam mais adequadas para uso como vírus de confrontação em testes de soroneurtralização (SN). Oitocentas e dez amostras de soros de duas regiões geograficamente distintas foram avaliadas à SN frente a seis diferentes cepas virais, incluindo tipos e subtipos diversos (BoHV-1.1: EVI123/98 e Los Angeles; BoHV-1.2a: SV265/96; BoHV-5a: EVI88/95; BoHV-5b: A663 e BoHV-5c: ISO95/97). A maior sensibilidade foi revelada pelo somatório de soropositivos identificados com as seis cepas utilizadas no estudo. Uma combinação de quatro vírus (BoHV-1.1: LA e EVI123/98, BoHV-5a: EVI88/95 e BoHV-5b: A663) foi capaz de detectar 99,1% das amostras soropositivas. Estes quatro vírus foram selecionados para serem utilizados em um levantamento soroepidemiológico com o intuito de estimar a prevalência das infecções causadas pelos BoHV-1 e BoHV-5 no Estado do Rio Grande do Sul. Para tanto, soros de 2200 fêmeas bovinas adultas (>24 meses), representativos da população bovina do Rio Grande do Sul, foram submetidos à SN frente às quatro cepas virais escolhidas. om esta combinação, a soroprevalência média das infecções por BoHV-1 e BoHV-5 encontrada foi de 29,2%. Além disso, analisando outros fatores que pudessem influenciar a prevalência das infecções, foram considerados fatores de risco o tipo de exploração corte, a ausência da prática de ordenha, o contato dos bovinos com ovinos/caprinos e animais silvestres, a venda de animais de reprodução, o uso de piquetes de parto/pós-parto, o uso de assistência veterinária privada e a criação de animais de raças européias de corte. Os resultados obtidos no presente trabalho demonstraram que, para que a SN seja capaz de detectar animais soropositivos ao BoHV-1 e BoHV-5 com a máxima sensibilidade, o teste deve ser realizado com várias amostras de BoHV-1 e BoHV-5, não necessariamente de tipos ou subtipos diferentes, pois amostras do mesmo tipo de vírus apresentarrm diferentes sensibilidades. Além disso, as amostras de confrontação podem variar de acordo com a região geográfica de origem dos soros. Os resultados obtidos nesse levantamento revelam que anticorpos anti-BoHV-1 e anti-BoHV-5 encontram-se amplamente distribuidos nos rebanhos gaúchos. No entanto, não foi possível determinar a prevalência tipo-específica destas infecções com os testes realizados. Assim, a proporção de animais que estão infectados com o BoHV-1 ou com o BoHV-5 (ou ambos) na região examinada permanece desconhecida. / In this study a search was carried out to determine which of a number of available strains/isolates of bovine herpesviruses types 1 (BoHV-1) and 5 (BoHV-5) would be more suitable for use as challenge virus in serum neutralization (SN) tests. Eight hundred and ten bovine serum samples collected from two geographically distinct regions were evaluated in SN tests against six BoHVs of different types and subtypes (BoHV-1.1: EVI123/98 and Los Angeles; BoHV-1.2a: SV265/96; BoHV-5a: EVI88/95; BoHV-5b: A663 and BoHV-5c: ISO95/97). The highest sensitivity was achieved when the SN-positive sera obtained with the six different viruses were added. A combination of four viruses (BoHV-1.1 LA, and EVI123/98, BoHV-5a EVI88/95 and BoHV-5b A663), was able to detect 99.1% of the seropositive samples. These four viruses were selected to carry out a seroepidemiological survey to estimate BoHV-1 and BoHV-5 prevalence in the state of Rio Grande do Sul. In order to achieve that, sera from 2,200 bovine female cows (>24 months-old), representative of the bovine population of Rio Grande do Sul state were tested on SN tests against the four selected viruses. With such combination, seroprevalence of BoHV-1 and BoHV-5 infections was 29.2%. After examining potential factors that might affect the prevalence of such infections, the following were considered as significant risk factors: the type of exploitation (beef cattle > dairy), use of milking procedures, concomitant presence of sheep, goats or wild animals in farm; sale of animals for reproductive purposes; use of pre and postparturition paddocks; use of private veterinary assistance and farming of European beef breeds. The results obtained here indicate that for the SN test to provide the highest sensitivity in detecting BoHV-1 and BoHV-5 seroposivive animals, it must be performed against a number of BoHV-1 and BoHV-5 strains, though not necessarily of different types and subtypes as viruses within a same subtype may display different sensitivities. Besides, challenge viruses may vary for geographically distinct areas. The serological survey performed with four distinct bovine herpesviruses reveal that antibodies to BoHV-1 and BoHV-5 are widely distributed among cattle flocks in Rio Grande do Sul. However, it was not possible to determine type-specific prevalence with the tests performed. Thus, the proportion of cattle actually infected with either BoHV-1 or BoHV-5 (or both) in the examined region remains undetermined.

O herpesvírus bovino tipo 1 (BoHV-1) é um dos principais agentes causadores de prejuízos econômicos em criações de bovinos. A vacinação tem sido amplamente utilizada para minimizar as perdas causadas por infecções pelo BoHV-1. Dentre as vacinas disponíveis, as vacinas desenvolvidas a partir de amostras virais recombinantes apresentam a vantagem de permitirem a diferenciação entre animais infectados e imunizados. Anteriormente, foi desenvolvida uma vacina recombinante diferencial com uma amostra de BoHV-1 brasileira baseada na deleção do gene que codifica a glicoproteína E (gE). No primeiro capítulo do presente trabalho, a segurança e imunogenicidade desta vacina recombinante inativada foi avaliada. Os experimentos de imunização, desafio e reativação da vacina diferencial em animais experimentalmente inoculados demonstraram que a vacina recombinante foi segura e eficiente ao minimizar ou mesmo prevenir os efeitos da infecção pelo BoHV-1. No segundo capítulo, a segurança da vacina gE- foi avaliada, através da imunização intramuscular (IM) de 22 vacas (14 BoHV-1 soronegativas e 8 soropositivas) prenhes. Foi observada soroconverão, mas não abortos e nem anormalidades fetais nos animais imunizados. Na segunda parte do mesmo estudo foi analizada a capacidade do vírus recombinante difundir-se em um rebanho bovino. Quatro terneiros foram inoculados pela rota intranasal (IN) com a amostra recombinante gE- e, posteriormente, adicionados a outros 16 animais com mesma idade e semelhante condição corporal durante 180 dias. Todos os animais foram monitorados diariamente em busca de sintomatologia clínica. Foi observada soroconversão apenas nos animais imunizados. Estes resultados indicam que, nas condições deste estudo, a amostra recombinante não causou nenhum dano nas vacas prenhes ou em seus terneiros e não foi capaz de difundir-se horizontalmente no rebanho. No terceiro capítulo foi avaliada a patogenicidade de uma amostra recombinante de BoHV-1 com deleção no gene Us9, utilizando coelhos como modelo experimental. Coelhos com quatro semanas de idade foram divididos em quatro grupos (A, B, C, D). Dois grupos (A e B) foram infectados via intranasal (IN) e dois (C e D) infectados via intraocular (IO). Em cada via de infecção, um grupo foi infectado com o vírus recombinante e o outro com o vírus selvagem (wt). Após a infecção IO, todos os animais, de ambos os grupos, desenvolveram intensa conjuntivite entre os dias 3 a 10 pós-inoculação (pi). Vírus infeccioso foi consistentemente isolado a partir dos suabes oculares entre os dias 1 a 10 pi chegando a um título máximo de 103,05 TCID50/mL. Nos grupos infectados pela via IN com BoHV-1 wt, 4/4 coelhos apresentaram sintomatologia característica da doença, tais como: pirexia, apatia, anorexia, tosse, secreção nasal severa (entre os dias 2 e 8 pi). Animais inoculados com o recombinante apresentaram apatia, anorexia e descarga nasal (entre os dias 3 e 7 pi). Vírus infeccioso foi isolado em diversos tecidos tanto nos animais inoculados com o vírus wt como recombinante. Ambos os vírus foram capazes de replicar nas mucosas. Análises histológicas dos tecidos dos animais demonstraram lesões em ambos os grupos. Este estudo apresentou que a proteína Us9 não tem um papel significante na patogenicidade in vivo. / Bovine herpesvirus type 1 (BoHV-1) is an the major cause of losses in cattle. Vaccination has been widely applied to minimize losses induced by BoHV-1 infections. Vacines developed from recombinant strains have the advantage of allow the differentiation between immunized and infected animals. Previously, a recombinant differential BoHV-1 vaccine based on a glycoprotein E deleted (gE) virus was developed. In the first chapter of the present work, the safety and immunogenicity of such recombinant, as a inactivate vaccine, was evaluated. The experiments showed that the DIVA vaccinne was safe and efficient in order to minimize or even prevent the clinical signs of the infection by BoHV- 1. In the second chapter of the present study, the safety of the gE- vaccine during pregnancy was evaluated by the intramuscular inoculation into 22 pregnant dams (14 BoHV-1 seronegative; 8 seropositive). Seroconversion was detected but no abortions, stillbirths or fetal abnormalities were seen after vaccination. In the second part of the same study, the potential of the gE- vaccine virus to spread among beef cattle under field conditions was examined. Four heifers were inoculated intranasally (IN) with the gE- vaccine and mixed with other 16 animals at the same age and body conditions, for 180 days. All animals were daily monitored for clinical signs.. Seroconversion was observed only in vaccinated heifers. These results indicate that, under the conditions of the present study, the gE vaccine virus did not cause any noticeable harmful effect on pregnant dams and on its offspring and did not spread horizontally among cattle. In the third chapter the pathogenicity of a US9 negative recombinant strain BoHV-1 using rabbits as an experimental model was avaluated. Rabbits four weeks old were divided in four groups (A, B, C, D) within four rabbits per group. Two groups were infected IN route and two via intraocular (IO). In each route, one group was infected by recombinant virus and the other infected by wild type (wt) virus. After IO infection, all rabbits developed intense conjunctivitis between days 3 to 10 pos infection (pi). Infective virus was consistently isolated from ocular swabs on days 1 to 10, reaching a maximum of 103.05 TCID50/mL. Animals infected in the IN rote with BoHV-1 wt, 4/4 rabbits showed characteristic signs of disease, which included pyrexia, apathy, anorexia, cough, severe nasal secretion between days 2 to 8. Rabbits inoculated with recombinant virus showed apathy, anorexia, nasal secretion (between days 3 and 7pi). Infectious virus was isolated in differents tissues as much as animals inoculated with wt and recombinant virus. Both virus were capable of replication in the mucosa nasal and ocular of the inoculated rabbits. Histopatological lesions were evident in both groups. In the present study showed which the US9 protein have not significantly in the pathogenicity in vivo.